126 related articles for article (PubMed ID: 9697747)
21. Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation.
Arad G; Levy R; Hillman D; Kaempfer R
Nat Med; 2000 Apr; 6(4):414-21. PubMed ID: 10742148
[TBL] [Abstract][Full Text] [Related]
22. Agonist properties of a microbial superantigen peptide.
Pontzer CH; Griggs ND; Johnson HM
Biochem Biophys Res Commun; 1993 Jun; 193(3):1191-7. PubMed ID: 8323541
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of staphylococcal enterotoxin A-induced superantigenic and lethal activities by a monoclonal antibody to toxic shock syndrome toxin-1.
Kum WW; Chow AW
J Infect Dis; 2001 Jun; 183(12):1739-48. PubMed ID: 11372026
[TBL] [Abstract][Full Text] [Related]
24. Tumor necrosis factor production by human T-cells stimulated with bacterial superantigens.
Imanishi K; Inada K; Akatsuka H; Gu Y; Igarashi H; Uchiyama T
Int J Immunopharmacol; 1995 Oct; 17(10):841-8. PubMed ID: 8707449
[TBL] [Abstract][Full Text] [Related]
25. Staphylococcal enterotoxin D is a promiscuous superantigen offering multiple modes of interactions with the MHC class II receptors.
Al-Daccak R; Mehindate K; Damdoumi F; Etongué-Mayer P; Nilsson H; Antonsson P; Sundström M; Dohlsten M; Sékaly RP; Mourad W
J Immunol; 1998 Jan; 160(1):225-32. PubMed ID: 9551975
[TBL] [Abstract][Full Text] [Related]
26. Temporal sequence and kinetics of proinflammatory and anti-inflammatory cytokine secretion induced by toxic shock syndrome toxin 1 in human peripheral blood mononuclear cells.
Kum WW; Cameron SB; Hung RW; Kalyan S; Chow AW
Infect Immun; 2001 Dec; 69(12):7544-9. PubMed ID: 11705931
[TBL] [Abstract][Full Text] [Related]
27. Reduction in Staphylococcus aureus growth and exotoxin production and in vaginal interleukin 8 levels due to glycerol monolaurate in tampons.
Strandberg KL; Peterson ML; Schaefers MM; Case LC; Pack MC; Chase DJ; Schlievert PM
Clin Infect Dis; 2009 Dec; 49(11):1711-7. PubMed ID: 19863450
[TBL] [Abstract][Full Text] [Related]
28. Intravenous immunoglobulin inhibits staphylococcal toxin-induced human mononuclear phagocyte tumor necrosis factor alpha production.
Darville T; Milligan LB; Laffoon KK
Infect Immun; 1997 Feb; 65(2):366-72. PubMed ID: 9009284
[TBL] [Abstract][Full Text] [Related]
29. Comparative analysis of lipopolysaccharide-induced tumor necrosis factor alpha activity in serum and lethality in mice and rabbits pretreated with the staphylococcal superantigen toxic shock syndrome toxin 1.
Dinges MM; Schlievert PM
Infect Immun; 2001 Nov; 69(11):7169-72. PubMed ID: 11598096
[TBL] [Abstract][Full Text] [Related]
30. MAIT cells launch a rapid, robust and distinct hyperinflammatory response to bacterial superantigens and quickly acquire an anergic phenotype that impedes their cognate antimicrobial function: Defining a novel mechanism of superantigen-induced immunopathology and immunosuppression.
Shaler CR; Choi J; Rudak PT; Memarnejadian A; Szabo PA; Tun-Abraham ME; Rossjohn J; Corbett AJ; McCluskey J; McCormick JK; Lantz O; Hernandez-Alejandro R; Haeryfar SMM
PLoS Biol; 2017 Jun; 15(6):e2001930. PubMed ID: 28632753
[TBL] [Abstract][Full Text] [Related]
31. Vaccination with non-toxic mutant toxic shock syndrome toxin-1 induces IL-17-dependent protection against Staphylococcus aureus infection.
Narita K; Hu DL; Asano K; Nakane A
Pathog Dis; 2015 Jun; 73(4):. PubMed ID: 25857736
[TBL] [Abstract][Full Text] [Related]
32. Staphylococcal toxic shock syndrome toxin 1-induced tumor necrosis factor alpha and interleukin-1 beta secretion by human peripheral blood monocytes and T lymphocytes is differentially suppressed by protein kinase inhibitors.
See RH; Chow AW
Infect Immun; 1992 Aug; 60(8):3456-9. PubMed ID: 1639516
[TBL] [Abstract][Full Text] [Related]
33. Role of the adhesion molecule lymphocyte function associated antigen 1 in toxic shock syndrome toxin 1-induced tumor necrosis factor alpha and interleukin-1 beta secretion by human monocytes.
See RH; Chow AW
Infect Immun; 1992 Nov; 60(11):4957-60. PubMed ID: 1399006
[TBL] [Abstract][Full Text] [Related]
34. Induction by toxic-shock-syndrome toxin-1 of a circulating tumor necrosis factor-like substance in rabbits and of immunoreactive tumor necrosis factor and interleukin-1 from human mononuclear cells.
Ikejima T; Okusawa S; van der Meer JW; Dinarello CA
J Infect Dis; 1988 Nov; 158(5):1017-25. PubMed ID: 3263446
[TBL] [Abstract][Full Text] [Related]
35. Staphylococcus aureus enterotoxins induce IL-8 secretion by human nasal epithelial cells.
O'Brien GJ; Riddell G; Elborn JS; Ennis M; Skibinski G
Respir Res; 2006 Sep; 7(1):115. PubMed ID: 16952309
[TBL] [Abstract][Full Text] [Related]
36. Mechanism of Staphylococcus aureus exotoxin A inhibition of Ig production by human B cells.
Moseley AB; Huston DP
J Immunol; 1991 Feb; 146(3):826-32. PubMed ID: 1988499
[TBL] [Abstract][Full Text] [Related]
37. Induction of tumour necrosis factor by staphylococcal toxic shock toxin 1.
de Azavedo JC; Drumm A; Jupin C; Parant M; Alouf JE; Arbuthnott JP
FEMS Microbiol Immunol; 1988 Jul; 1(2):69-74. PubMed ID: 3273461
[TBL] [Abstract][Full Text] [Related]
38. Role of staphylococcal superantigen in atopic dermatitis: influence on keratinocytes.
Kim KH; Han JH; Chung JH; Cho KH; Eun HC
J Korean Med Sci; 2006 Apr; 21(2):315-23. PubMed ID: 16614521
[TBL] [Abstract][Full Text] [Related]
39. Activator protein-1 (AP-1) is stimulated by microbial superantigens in human monocytic cells.
Trede NS; Chatila T; Geha RS
Eur J Immunol; 1993 Sep; 23(9):2129-35. PubMed ID: 8370396
[TBL] [Abstract][Full Text] [Related]
40. Pathogenesis of the toxic shock syndrome: T cell mediated lethal shock caused by the superantigen TSST-1.
Miethke T; Duschek K; Wahl C; Heeg K; Wagner H
Eur J Immunol; 1993 Jul; 23(7):1494-500. PubMed ID: 8325325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
